The efficacy of GIP(3-30)NH2 as a GIP receptor antagonist in humans

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
Article number557
JournalDiabetologia
Volume62
Issue numberSupæ. 1/SI
Pages (from-to)S269
Number of pages1
ISSN0012-186X
Publication statusPublished - 2019
Event55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) - Barcelona, Spain
Duration: 16 Sep 201920 Sep 2019

Conference

Conference55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
CountrySpain
CityBarcelona
Period16/09/201920/09/2019

ID: 230571329